Newborn screening by rapid whole genome sequencing (IMAGE)
Caption
Because highly successful NBS has not kept pace with genome or therapeutic innovation, we adapted rWGS for comprehensive NBS. NBS-rWGS for 388 disorders had 99.7% specificity, 88.8% sensitivity, and could have avoided symptoms completely in seven of 2,208 critically ill infants, mostly in 21, and partially in 13.
Credit
Rady Children's Institute for Genomic Medicine
Usage Restrictions
none
License
Original content